Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News
4/29/2025
AstraZeneca's China Business Recovers in Q1 2025 Amid Easing Regulator...
4/29/2025
China Orders Drugmakers, Hospitals to Study US Import Replacements
4/29/2025
State Council Approves Draft Medical Security Law, Strengthening Fund ...
4/29/2025
53 Original Research Drugs Approved in China in Early 2025
4/29/2025
BeiGene's Novel Cancer Drug Sonrotoclax Seeks Approval in China
4/29/2025
ConjugateBio Secures Exclusive Option for Escugen's EZWi-Fit® Platfor...
4/29/2025
Europe Emerges as Key Partner for China Pharma Deals Amid US Market Sh...
4/29/2025
AmCham China Reports Chinese Tariff Exemptions for Some Pharma Firms A...
4/29/2025
Innovent Announces NMPA Approval of Limertinib
4/29/2025
InnoCare's Orelabrutinib Receives NMPA Approval as First-Line Therapy ...
4/29/2025
Hengrui Secures Approval for Hong Kong IPO
4/29/2025
China NMPA Suspends Digoxin API Imports from VITAL LABS
4/29/2025
China's Hospital Drug Market Shows Slight Growth in 2024, Driven by On...
4/29/2025
Frontera's Gene Therapy FT-017 Achieves Dual Regulatory Clearance in U...
4/29/2025
JW and Juno Forge sLVV Licensing Agreement to Advance Cell Therapy Man...
4/29/2025
XellSmart Receives NMPA Approval for Landmark Trial of "On-Demand" iP...
4/29/2025
CentyMed's Novel EGFR/CD3 BsAb CMDE005 Receives FDA Green Light for Cl...
4/29/2025
Ribo Life Science Files for IPO on HKSE, Backed by CICC and Citi
4/29/2025
PegBio Poised for IPO on Hong Kong Stock Exchange Following Successful...
4/29/2025
3SBio Advances Novel MUC17-Targeting Therapy SSS59 into Global Phase 1...
4/29/2025
Innovent Initiates Global Phase 1 Trial for ADC IBI3020
4/29/2025
DualityBio and AstraZeneca Unite to Investigate Novel Lung Cancer Comb...
4/29/2025
Qyuns Sets Up Newco for Global Rights to Its Novel Long-Acting BsAb QX...
4/29/2025
Akeso's BsAb Shows Promising Survival Benefit in Lung Cancer Trial
4/26/2025
Recent Executive Moves
4/25/2025
China's Innovative Drug Licensing Deals Soar, Big Pharma Leads the Buy...
4/25/2025
China Greenlights Recordati's Long-Acting Pasireotide for Uncontrolled...
4/25/2025
Akeso's Ivonescimab Gains Second Approval in China
4/25/2025
Akeso's Penpulimab Secures FDA Approval for Nasopharyngeal Carcinoma
4/25/2025
NMPA Approves Expanded Use of JNJ's Rybrevant for Advanced EGFR-Mutate...
Page:
1
/
48
Total number of articles:
1430
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit